D-dimer Testing Market Analysis

D-dimer Testing Market Analysis

To get key market trends

  Download Free Sample

Based on testing method, the d-dimer testing market is segmented into enzyme-linked immunosorbent assay (ELISA), latex-enhanced immuno-turbidimetric assays, fluorescence immunoassays, and others. The enzyme-linked immunosorbent assay (ELISA) segment held the largest revenue size over USD 460 million in 2022 and is estimated to witness significant growth more than USD 700 million by 2032. ELISA assays for D-dimer testing are highly sensitive, capable of detecting even low levels of D-dimer in blood samples. This sensitivity allows for the accurate identification of thrombotic events and helps in ruling out or confirming the presence of blood clots. Furthermore, an increase in the availability of testing method coupled with several other businesses working towards creating innovative technology will support the segment's revenue.
 

D-dimer testing market is bifurcated based on the application including deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), others. The deep vein thrombosis (DVT) segment is anticipated to grow over USD 770 million by 2032. DVT is a widespread medical condition that frequently remains untreated and mostly affects hospitalized patients due to immobility. Due to this, DVT is more common, and its accompanying consequences are more likely to occur. In the U.S., venous thrombosis affects more than 200,000 people annually, per research studies. Therefore, increasing prevalence of deep vein thrombosis (DVT) is anticipated to boost d-dimer testing adoption.
 

The d-dimer testing market is segmented by end-use into hospitals, diagnostic centers, research institutes, and others. Diagnostic centers segment held a significant share in the global market accounting for more than 29% business share in 2022 and is estimated to witness significant revenue over USD 600 million by 2032. The diagnostic centers segment is anticipated to hold high growth potential during the analysis period. Due to the widespread availability of innovative and affordable treatments, factors including the increase in laboratory testing and growing preference for diagnostics laboratories will fuel market expansion. These facilities also offer early and precise disease diagnosis and patient treatment, which is anticipated to accelerate segment expansion.
 

U.S. d-dimer testing market accounted for more than USD 450 billion in 2022 and will grow momentously more than USD 615 billion by 2032. The affordability of d-dimer testing among the target population base and ongoing technological developments are primarily responsible for the market growth. Further, the region's high healthcare spending on health care management and rising disposable income will spur the North America market forecasts. Also, the substantial presence of well-established market participants and the favourable regulatory environment result in a number of product approvals and launches, particularly in the U.S. hence, the potential for market expansion will stimulate over the coming years.